Prostaglandin endoperoxide synthase: Why two isoforms?

Christopher S. Williams, Raymond N. DuBois

Research output: Contribution to journalArticle

478 Citations (Scopus)

Abstract

Prostaglandin endoperoxide synthase-1 [prostaglandin G/H synthase-1 (PGHS- 1)] and PGHS-2 are key enzymes in the conversion of arachidonic acid to prostaglandins and other eicosanoids. We refer to these isoforms as cyclooxygenase-1 (COX-1) and COX-2 in this review. This brief review focuses on recent developments in the study of these enzymes. Alterations in the expression levels of COX-2 result in distinct phenotypic changes in intestinal epithelial cells. Overexpression of COX-2 in intestinal epithelial cells results in increased adhesion to extracellular matrix proteins and inhibition of apoptosis. Disruption of the COX-2 gene in mice results in renal dysplasia, cardiac fibrosis, and defects in the ovary. Interestingly, disruption of the COX-1 gene results in distinct phenotypic changes different from those observed for COX-2. COX-1 null mice survive well, have no gastric pathology, and show less indomethacin-induced gastric ulceration than wild- type mice. These two closely related enzymes must have distinct functions in the organism, since lack of their expression causes distinct phenotypic changes for each respective isoform.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume270
Issue number3 33-3
StatePublished - 1996
Externally publishedYes

Fingerprint

Cyclooxygenase 1
Prostaglandin-Endoperoxide Synthases
Protein Isoforms
Stomach
Enzymes
Epithelial Cells
Eicosanoids
Extracellular Matrix Proteins
Cyclooxygenase 2
Arachidonic Acid
Indomethacin
Genes
Prostaglandins
Ovary
Fibrosis
Apoptosis
Pathology
Kidney

Keywords

  • colorectal cancer
  • cyclooxygenase
  • eicosanoid
  • intestinal epithelial cells

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology
  • Physiology (medical)

Cite this

Prostaglandin endoperoxide synthase : Why two isoforms? / Williams, Christopher S.; DuBois, Raymond N.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 270, No. 3 33-3, 1996.

Research output: Contribution to journalArticle

Williams, Christopher S. ; DuBois, Raymond N. / Prostaglandin endoperoxide synthase : Why two isoforms?. In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 1996 ; Vol. 270, No. 3 33-3.
@article{346137acaba744cfaa61e803c947b76e,
title = "Prostaglandin endoperoxide synthase: Why two isoforms?",
abstract = "Prostaglandin endoperoxide synthase-1 [prostaglandin G/H synthase-1 (PGHS- 1)] and PGHS-2 are key enzymes in the conversion of arachidonic acid to prostaglandins and other eicosanoids. We refer to these isoforms as cyclooxygenase-1 (COX-1) and COX-2 in this review. This brief review focuses on recent developments in the study of these enzymes. Alterations in the expression levels of COX-2 result in distinct phenotypic changes in intestinal epithelial cells. Overexpression of COX-2 in intestinal epithelial cells results in increased adhesion to extracellular matrix proteins and inhibition of apoptosis. Disruption of the COX-2 gene in mice results in renal dysplasia, cardiac fibrosis, and defects in the ovary. Interestingly, disruption of the COX-1 gene results in distinct phenotypic changes different from those observed for COX-2. COX-1 null mice survive well, have no gastric pathology, and show less indomethacin-induced gastric ulceration than wild- type mice. These two closely related enzymes must have distinct functions in the organism, since lack of their expression causes distinct phenotypic changes for each respective isoform.",
keywords = "colorectal cancer, cyclooxygenase, eicosanoid, intestinal epithelial cells",
author = "Williams, {Christopher S.} and DuBois, {Raymond N.}",
year = "1996",
language = "English (US)",
volume = "270",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "3 33-3",

}

TY - JOUR

T1 - Prostaglandin endoperoxide synthase

T2 - Why two isoforms?

AU - Williams, Christopher S.

AU - DuBois, Raymond N.

PY - 1996

Y1 - 1996

N2 - Prostaglandin endoperoxide synthase-1 [prostaglandin G/H synthase-1 (PGHS- 1)] and PGHS-2 are key enzymes in the conversion of arachidonic acid to prostaglandins and other eicosanoids. We refer to these isoforms as cyclooxygenase-1 (COX-1) and COX-2 in this review. This brief review focuses on recent developments in the study of these enzymes. Alterations in the expression levels of COX-2 result in distinct phenotypic changes in intestinal epithelial cells. Overexpression of COX-2 in intestinal epithelial cells results in increased adhesion to extracellular matrix proteins and inhibition of apoptosis. Disruption of the COX-2 gene in mice results in renal dysplasia, cardiac fibrosis, and defects in the ovary. Interestingly, disruption of the COX-1 gene results in distinct phenotypic changes different from those observed for COX-2. COX-1 null mice survive well, have no gastric pathology, and show less indomethacin-induced gastric ulceration than wild- type mice. These two closely related enzymes must have distinct functions in the organism, since lack of their expression causes distinct phenotypic changes for each respective isoform.

AB - Prostaglandin endoperoxide synthase-1 [prostaglandin G/H synthase-1 (PGHS- 1)] and PGHS-2 are key enzymes in the conversion of arachidonic acid to prostaglandins and other eicosanoids. We refer to these isoforms as cyclooxygenase-1 (COX-1) and COX-2 in this review. This brief review focuses on recent developments in the study of these enzymes. Alterations in the expression levels of COX-2 result in distinct phenotypic changes in intestinal epithelial cells. Overexpression of COX-2 in intestinal epithelial cells results in increased adhesion to extracellular matrix proteins and inhibition of apoptosis. Disruption of the COX-2 gene in mice results in renal dysplasia, cardiac fibrosis, and defects in the ovary. Interestingly, disruption of the COX-1 gene results in distinct phenotypic changes different from those observed for COX-2. COX-1 null mice survive well, have no gastric pathology, and show less indomethacin-induced gastric ulceration than wild- type mice. These two closely related enzymes must have distinct functions in the organism, since lack of their expression causes distinct phenotypic changes for each respective isoform.

KW - colorectal cancer

KW - cyclooxygenase

KW - eicosanoid

KW - intestinal epithelial cells

UR - http://www.scopus.com/inward/record.url?scp=0029924110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029924110&partnerID=8YFLogxK

M3 - Article

C2 - 8638704

AN - SCOPUS:0029924110

VL - 270

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 3 33-3

ER -